Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1927-2026

Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx) Recall

Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)

FDA recall Class II

Ongoing

FDA lists this Class II recall for Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx). Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1927-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 20, 2026
FDA report date
Apr 29, 2026
Quantity in commerce
163 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)

Affected model & UDI checker

Search the exact identifiers published for Z-1927-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
SEQ0067Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)Check source noticeNot specified
FDA code information

Model Number: SEQ0067. Lot Numbers: 24346, 24386, 24488.

View the original FDA recall notice

Why was this product recalled?

Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Foundation Medicine, Inc. take?

Foundation Medicine notified consignees via emailed letter on about 03/20/2026. Consignees were instructed to review, complete, sign and return the provided business reply form and review inventory and identify affected units, quarantine those units, and return to the FMI Boston Warehouse quarantine location via standard laboratory transfer practices. Consignees were also instructed to forward the notification to anyone within the facility that should be informed and if there is any impact that requires this notice to be forwarded to another facility, including facilities where units of inventory may have been transferred, contact that facility and provide them with this letter. Consignees were asked to retain the letter with laboratory records made aware that Foundation Medicine will work with the supplier of these components to replace impacted units.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology